The prevalence and clinical characteristics of pertussis-associated pneumonia among infants in Botswana

Abstract Background There are scant data on the prevalence and clinical course of pertussis disease among infants with pneumonia in low- and middle-income countries. While pertussis vaccination coverage is high (≥90%) among infants in Botswana, human immunodeficiency virus (HIV) infection affects ne...

Full description

Bibliographic Details
Main Authors: Bahaa Abu-Raya, David M. Goldfarb, Marek Smieja, Kathy Luinstra, Melissa Richard-Greenblatt, Andrew P. Steenhoff, Kristen A. Feemster, Tonya Arscott-Mills, Coleen K. Cunningham, Samir S. Shah, Mohamed Zaakir Patel, Matthew S. Kelly, Manish Sadarangani
Format: Article
Language:English
Published: BMC 2019-11-01
Series:BMC Pediatrics
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12887-019-1820-0
id doaj-2d414e4c2e3c4b0fbe863fae0cefd3a3
record_format Article
spelling doaj-2d414e4c2e3c4b0fbe863fae0cefd3a32020-11-25T04:08:30ZengBMCBMC Pediatrics1471-24312019-11-011911610.1186/s12887-019-1820-0The prevalence and clinical characteristics of pertussis-associated pneumonia among infants in BotswanaBahaa Abu-Raya0David M. Goldfarb1Marek Smieja2Kathy Luinstra3Melissa Richard-Greenblatt4Andrew P. Steenhoff5Kristen A. Feemster6Tonya Arscott-Mills7Coleen K. Cunningham8Samir S. Shah9Mohamed Zaakir Patel10Matthew S. Kelly11Manish Sadarangani12Vaccine Evaluation Center, BC Children’s Hospital Research Institute, University of British ColumbiaDivision of Infectious Diseases, Department of Pediatrics, University of British ColumbiaDepartment of Pathology and Molecular Medicine, McMaster UniversityDepartment of Pathology and Molecular Medicine, McMaster UniversityDepartment of Pathology and Molecular Medicine, McMaster UniversityBotswana-University of Pennsylvania PartnershipDivision of Infectious Diseases, Children’s Hospital of PhiladelphiaBotswana-University of Pennsylvania PartnershipDivision of Pediatric Infectious Diseases, Duke University Medical CenterDivisions of Hospital Medicine and Infectious Diseases, Cincinnati Children’s Hospital Medical CenterDepartment of Paediatrics and Adolescent Health, University of Botswana School of MedicineBotswana-University of Pennsylvania PartnershipVaccine Evaluation Center, BC Children’s Hospital Research Institute, University of British ColumbiaAbstract Background There are scant data on the prevalence and clinical course of pertussis disease among infants with pneumonia in low- and middle-income countries. While pertussis vaccination coverage is high (≥90%) among infants in Botswana, human immunodeficiency virus (HIV) infection affects nearly one-third of pregnancies. We aimed to evaluate the prevalence and clinical course of pertussis disease in a cohort of HIV-unexposed uninfected (HUU), HIV-exposed uninfected (HEU), and HIV-infected infants with pneumonia in Botswana. Methods We recruited children 1–23 months of age with clinical pneumonia at a tertiary care hospital in Gaborone, Botswana between April 2012 and June 2016. We obtained nasopharyngeal swab specimens at enrollment and tested these samples using a previously validated in-house real-time PCR assay that detects a unique sequence of the porin gene of Bordetella pertussis. Results B. pertussis was identified in 1/248 (0.4%) HUU, 3/110 (2.7%) HEU, and 0/33 (0.0%) HIV-infected children. All pertussis-associated pneumonia cases occurred in infants 1–5 months of age (prevalence, 1.0% [1/103] in HUU and 4.8% [3/62] in HEU infants). No HEU infants with pertussis-associated pneumonia were taking cotrimoxazole prophylaxis at the time of hospital presentation. One HUU infant with pertussis-associated pneumonia required intensive care unit admission for mechanical ventilation, but there were no deaths. Conclusions The prevalence of pertussis was low among infants and young children with pneumonia in Botswana. Although vaccination against pertussis in pregnancy is designed to prevent classical pertussis disease, reduction of pertussis-associated pneumonia might be an important additional benefit.http://link.springer.com/article/10.1186/s12887-019-1820-0Bordetella pertussisHIV-exposed uninfectedPneumonia
collection DOAJ
language English
format Article
sources DOAJ
author Bahaa Abu-Raya
David M. Goldfarb
Marek Smieja
Kathy Luinstra
Melissa Richard-Greenblatt
Andrew P. Steenhoff
Kristen A. Feemster
Tonya Arscott-Mills
Coleen K. Cunningham
Samir S. Shah
Mohamed Zaakir Patel
Matthew S. Kelly
Manish Sadarangani
spellingShingle Bahaa Abu-Raya
David M. Goldfarb
Marek Smieja
Kathy Luinstra
Melissa Richard-Greenblatt
Andrew P. Steenhoff
Kristen A. Feemster
Tonya Arscott-Mills
Coleen K. Cunningham
Samir S. Shah
Mohamed Zaakir Patel
Matthew S. Kelly
Manish Sadarangani
The prevalence and clinical characteristics of pertussis-associated pneumonia among infants in Botswana
BMC Pediatrics
Bordetella pertussis
HIV-exposed uninfected
Pneumonia
author_facet Bahaa Abu-Raya
David M. Goldfarb
Marek Smieja
Kathy Luinstra
Melissa Richard-Greenblatt
Andrew P. Steenhoff
Kristen A. Feemster
Tonya Arscott-Mills
Coleen K. Cunningham
Samir S. Shah
Mohamed Zaakir Patel
Matthew S. Kelly
Manish Sadarangani
author_sort Bahaa Abu-Raya
title The prevalence and clinical characteristics of pertussis-associated pneumonia among infants in Botswana
title_short The prevalence and clinical characteristics of pertussis-associated pneumonia among infants in Botswana
title_full The prevalence and clinical characteristics of pertussis-associated pneumonia among infants in Botswana
title_fullStr The prevalence and clinical characteristics of pertussis-associated pneumonia among infants in Botswana
title_full_unstemmed The prevalence and clinical characteristics of pertussis-associated pneumonia among infants in Botswana
title_sort prevalence and clinical characteristics of pertussis-associated pneumonia among infants in botswana
publisher BMC
series BMC Pediatrics
issn 1471-2431
publishDate 2019-11-01
description Abstract Background There are scant data on the prevalence and clinical course of pertussis disease among infants with pneumonia in low- and middle-income countries. While pertussis vaccination coverage is high (≥90%) among infants in Botswana, human immunodeficiency virus (HIV) infection affects nearly one-third of pregnancies. We aimed to evaluate the prevalence and clinical course of pertussis disease in a cohort of HIV-unexposed uninfected (HUU), HIV-exposed uninfected (HEU), and HIV-infected infants with pneumonia in Botswana. Methods We recruited children 1–23 months of age with clinical pneumonia at a tertiary care hospital in Gaborone, Botswana between April 2012 and June 2016. We obtained nasopharyngeal swab specimens at enrollment and tested these samples using a previously validated in-house real-time PCR assay that detects a unique sequence of the porin gene of Bordetella pertussis. Results B. pertussis was identified in 1/248 (0.4%) HUU, 3/110 (2.7%) HEU, and 0/33 (0.0%) HIV-infected children. All pertussis-associated pneumonia cases occurred in infants 1–5 months of age (prevalence, 1.0% [1/103] in HUU and 4.8% [3/62] in HEU infants). No HEU infants with pertussis-associated pneumonia were taking cotrimoxazole prophylaxis at the time of hospital presentation. One HUU infant with pertussis-associated pneumonia required intensive care unit admission for mechanical ventilation, but there were no deaths. Conclusions The prevalence of pertussis was low among infants and young children with pneumonia in Botswana. Although vaccination against pertussis in pregnancy is designed to prevent classical pertussis disease, reduction of pertussis-associated pneumonia might be an important additional benefit.
topic Bordetella pertussis
HIV-exposed uninfected
Pneumonia
url http://link.springer.com/article/10.1186/s12887-019-1820-0
work_keys_str_mv AT bahaaaburaya theprevalenceandclinicalcharacteristicsofpertussisassociatedpneumoniaamonginfantsinbotswana
AT davidmgoldfarb theprevalenceandclinicalcharacteristicsofpertussisassociatedpneumoniaamonginfantsinbotswana
AT mareksmieja theprevalenceandclinicalcharacteristicsofpertussisassociatedpneumoniaamonginfantsinbotswana
AT kathyluinstra theprevalenceandclinicalcharacteristicsofpertussisassociatedpneumoniaamonginfantsinbotswana
AT melissarichardgreenblatt theprevalenceandclinicalcharacteristicsofpertussisassociatedpneumoniaamonginfantsinbotswana
AT andrewpsteenhoff theprevalenceandclinicalcharacteristicsofpertussisassociatedpneumoniaamonginfantsinbotswana
AT kristenafeemster theprevalenceandclinicalcharacteristicsofpertussisassociatedpneumoniaamonginfantsinbotswana
AT tonyaarscottmills theprevalenceandclinicalcharacteristicsofpertussisassociatedpneumoniaamonginfantsinbotswana
AT coleenkcunningham theprevalenceandclinicalcharacteristicsofpertussisassociatedpneumoniaamonginfantsinbotswana
AT samirsshah theprevalenceandclinicalcharacteristicsofpertussisassociatedpneumoniaamonginfantsinbotswana
AT mohamedzaakirpatel theprevalenceandclinicalcharacteristicsofpertussisassociatedpneumoniaamonginfantsinbotswana
AT matthewskelly theprevalenceandclinicalcharacteristicsofpertussisassociatedpneumoniaamonginfantsinbotswana
AT manishsadarangani theprevalenceandclinicalcharacteristicsofpertussisassociatedpneumoniaamonginfantsinbotswana
AT bahaaaburaya prevalenceandclinicalcharacteristicsofpertussisassociatedpneumoniaamonginfantsinbotswana
AT davidmgoldfarb prevalenceandclinicalcharacteristicsofpertussisassociatedpneumoniaamonginfantsinbotswana
AT mareksmieja prevalenceandclinicalcharacteristicsofpertussisassociatedpneumoniaamonginfantsinbotswana
AT kathyluinstra prevalenceandclinicalcharacteristicsofpertussisassociatedpneumoniaamonginfantsinbotswana
AT melissarichardgreenblatt prevalenceandclinicalcharacteristicsofpertussisassociatedpneumoniaamonginfantsinbotswana
AT andrewpsteenhoff prevalenceandclinicalcharacteristicsofpertussisassociatedpneumoniaamonginfantsinbotswana
AT kristenafeemster prevalenceandclinicalcharacteristicsofpertussisassociatedpneumoniaamonginfantsinbotswana
AT tonyaarscottmills prevalenceandclinicalcharacteristicsofpertussisassociatedpneumoniaamonginfantsinbotswana
AT coleenkcunningham prevalenceandclinicalcharacteristicsofpertussisassociatedpneumoniaamonginfantsinbotswana
AT samirsshah prevalenceandclinicalcharacteristicsofpertussisassociatedpneumoniaamonginfantsinbotswana
AT mohamedzaakirpatel prevalenceandclinicalcharacteristicsofpertussisassociatedpneumoniaamonginfantsinbotswana
AT matthewskelly prevalenceandclinicalcharacteristicsofpertussisassociatedpneumoniaamonginfantsinbotswana
AT manishsadarangani prevalenceandclinicalcharacteristicsofpertussisassociatedpneumoniaamonginfantsinbotswana
_version_ 1724425423911124992